Organovo Holdings Stock (NASDAQ:ONVO), Quotes and News Summary

Q: What sector and industry does Organovo Holdings (ONVO) operate in?

Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.

Open	$1.100
Close	-
Volume / Avg.	455.006K / 977.528K
Day Range	1.090 - 1.290
52 Wk Range	0.891 - 2.240
Market Cap	$12.899M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	1.61%
Days to Cover	1

Recent News

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Avi Kapoor

Why Organovo Stock Is Up Today

Organovo released the complete details of its 16-week, randomized, placebo-controlled, multi-center Phase 2 study of the non-steroidal, non-bile acid FXR agonist FXR314 for the treatment of metabolic function-associated steatohepatitis (MASH).

Erica Kollmann

Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also rose, gaining, 0.80% to 5,164.30.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Organovo Holdings Inc

Sector

Health Care

Industry

Biotechnology

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dim...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Organovo Holdings (ONVO) stock?

You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.

View our list of the best stock brokerages.

Who are Organovo Holdings's (ONVO) competitors?

Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Coeptis Therapeutics (NASDAQ:COEP).

What is the target price for Organovo Holdings (ONVO) stock?

The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Organovo Holdings (ONVO)?

The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.09 last updated Today at April 18, 2024 at 9:26 AM EDT.

Does Organovo Holdings (ONVO) pay a dividend?

There are no upcoming dividends for Organovo Holdings.

When is Organovo Holdings (NASDAQ:ONVO) reporting earnings?

Organovo Holdings’s Q4 earnings are confirmed for Friday, July 12, 2024.

Is Organovo Holdings (ONVO) going to split?

There is no upcoming split for Organovo Holdings.

What sector and industry does Organovo Holdings (ONVO) operate in?

Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-